Delivery Order 75F40120D00031-75F40121F19002

Award Date 9/28/21
Potential Completion Date 9/27/22
Potential Value $386K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Falls Church, VA 22042, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Iqvia Government Solutions Inc. was awarded a $381,366.10 firm fixed price delivery order against an unspecified contract vehicle to provide the Food and Drug Administration access to over-the-counter drug utilization data. The one-year contract has a period of performance through September 2021 and no set-aside designation was used. The data will support the FDA's regulatory programs and efforts to protect public health by enhancing post-market drug safety surveillance and evaluation of OTC...
This contract was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to U.S. federal agencies. The $2,960,301.96 Firm Fixed Price contract is for ACCESS TO OVER THE COUNTER DRUG UTILIZATION DATA to support the FDA's Drug Utilization Program. This contract is not set aside. Iqvia Government Solutions Inc. has established itself as a trusted partner for federal healthcare agencies, providing a...
Iqvia Government Solutions Inc. was awarded a firm fixed price purchase order contract valued at $2,171,621.71 by the Department of Health and Human Services' Food and Drug Administration to obtain access to data resources enabling global capture of pharmaceutical sales data by country. This contract delivers against the original solicitation requesting pharmaceutical sales information to support the FDA in monitoring drug markets internationally. It was awarded without a set-aside designation...
Iqvia Government Solutions Inc. has been awarded a $3,667,351.10 firm fixed price delivery order contract by the Department of Health and Human Services' Food and Drug Administration to provide hospital drug data. The contract has no set-aside designation and work will be performed in Silver Spring, Maryland through April 2025. This delivery order was issued against Iqvia's indefinite delivery, indefinite quantity contract vehicle worth up to $9 million to supply hospital drug data in support of...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a for-profit provider of healthcare data, analytics, and related services to U.S. federal agencies. The order, valued at $550,923.02, is for "International Sales Data" and has a completion date of February 1, 2019. Iqvia has held multiple prime and subcontracts with the FDA and other agencies to provide prescription drug...
This is a $11,394,396.89 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. to provide national and international pharmaceutical sales data. The contract has no set-aside designation. The contract is to support the FDA's Center for Drug Evaluation and Research in estimating trends in drug sales, pricing, and volume of distribution to inform regulatory decision-making. It provides ongoing access to pharmaceutical sales data...
IQVIA Government Solutions Inc. was awarded a $68,332.85 firm fixed price delivery order contract by the Department of Health and Human Services' Food and Drug Administration to provide Longitudinal Prescription (LRX) Data Switch Reports. The contract has a period of performance of one year, running from December 6, 2023 through December 5, 2024. IQVIA will deliver the requested prescription drug data and reporting services from its established LRX Data Switch program to support the FDA's...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Iqvia Government Solutions Inc. on a firm fixed price basis. The contract is for the delivery of prescription drug data, over-the-counter drug data, hospital drug data, and related analytics services. The potential value of the contract is $1,494,582.69, and the completion date is March 31, 2022. Iqvia has held multiple federal contracts and subcontracts to provide...
This federal contract award to Iqvia Government Solutions Inc. is for "ACCESS TO INTERNATIONAL PRESCRIPTION DRUG CONCISE GUIDE REPORTS REMIS SP-18-015" and was issued by the Office of the Assistant Secretary for Administration, a civilian agency. The contract is a $161,031.57 Firm Fixed Price Delivery Order under the Chief Information Officer Commodities and Solutions (CIO-CS) Master Contract. Iqvia, a leading provider of healthcare data and analytics, will deliver access to...
This federal contract award to Iqvia Government Solutions Inc., a for-profit organization, provides the Department of Health and Human Services (HHS) with subscription access to prescription drug data. The $7,793,562.89 contract has a firm fixed price and is being delivered as a delivery order under the Chief Information Officer Commodities and Solutions (CIO-CS) contract vehicle. The contract has no set-aside designation and the period of performance runs through September 6, 2023. Iqvia...
  • 75F40120D00031
    Indefinite Delivery Contract
  • 75F40120D00031-75F40121F19002
    Delivery Order

Iqvia Government Solutions Inc. was awarded a $385,752.76 firm fixed price delivery order against an unspecified contract vehicle to provide the Food and Drug Administration access to over-the-counter drug utilization data. The one-year contract has a completion date of September 27, 2022 and was awarded on September 28, 2021 without a set-aside designation. As the prime contractor, Iqvia will leverage its expertise in commercial healthcare data and analytics to support the FDA's regulatory and research efforts overseeing non-prescription medications used by American consumers.

Generated 1/3/24, 5:18 PM